Development of the Consumer Involvement & Engagement Toolkit: a digital resource to build capacity for undertaking patient-centred clinical trials in Australia
Tanya Symons A , Janelle Bowden B , Anne McKenzie C , Julia Fallon-Ferguson D , Leanne Weekes E , James Ansell F , Rinki Murphy G , Shilpa Jesudason H , Manoj Saxena I , Alistair Nichol J K and Nicola Straiton L *A
B
C
D
E
F
G
H
I
J
K
L
Abstract
Objective: This manuscript describes the novel approach to developing a toolkit to support meaningful consumer involvement in clinical trials in Australia to help guide others in considering the development of similar resources.The toolkit aims to support greater consumer involvement in shaping how clinical research is prioritised, designed and conducted. Type of program or service: A working group of researchers, research organisations and consumers was established to co-develop the Consumer Involvement and Engagement Toolkit (the ‘Toolkit’), a digital resource to guide researchers and organisations regarding consumer involvement in clinical trials. Findings: A literature review and international scan of best practice revealed numerous resources outlining best practice for consumer involvement in clinical research and clear evidence of its impact and value. Through a novel content-sharing process, we were able to utilise these resources to develop a comprehensive Toolkit for researchers and research organisations that provides world-class guidance. Lessons learnt: There is a growing movement to ensure consumer involvement in healthcare, including in clinical research. We discovered its proponents were willing to share their tools and resources to promote international consumer involvement. Although these international tools and resources needed adaptation to suit the Australian research environment, this was achievable with far less effort than developing them from scratch.References
3 Canadian Institutes of Health Research. Canada’s strategy for patient-oriented research. Canada; CIHR: 2021 [cited 2021 Dec 12]. Available from: cihr-irsc.gc.ca/e/41204.html
4 Australian Commission on Safety and Quality in Health Care: National Clinical Trials Governance Framework. Sydney: ACSQHC; 2020 [cited 2021 Dec 12]. Available from: www.safetyandquality.gov.au/standards/clinical-trials
8 Australian Clinical Trials Alliance. Consumer involvement consultation report. Melbourne: ACTA; 2018 [cited 2021 Dec 12]. Available from: clinicaltrialsalliance.org.au/resource/acta-consumer-involvement-consultation-report-2/
9 National Institute of Health Research (NIHR): Involve.UK: NIHR; 2022 [cited 2022, May 17]. Available from www.nihr.ac.uk/documents/ppi-patient-and-public-involvement-resources-for-applicants-to-nihr-research-programmes/23437
10 Clinical Trials Transformation Initiative. Durham NC: CTTI; 2022 [cited 2022 May 17]. Available from: ctti-clinicaltrials.org/
11 Patient-Centred Outcomes Research Institute (PCORI). Washington DC: PCORI; 2022 [cited 2022 May 17]. Available from: www.pcori.org/
12 Australian Clinical Trials Alliance. Toolkit for researchers and research organisations. Melbourne: ACTA; 2019 [cited 2022 May 17]. Available from: involvementtoolkit.clinicaltrialsalliance.org.au/toolkit
13 National Institute of Health Research Clinical Trials Toolkit. Routemap. Southampton, UK: NIHR; 2022 [cited 2021 Dec 12]. Available from: www.ct-toolkit.ac.uk/routemap/
14 Web Content Accessibility Guidelines. WCAG 2 Overview. Cambridge, MA: WAI; 2018 [cited 2021 Dec 12]. Available from: www.w3.org/WAI/standards-guidelines/wcag/
15 National Health and Medical Research Council and Consumers Health Forum of Australia. Statement on consumer and community involvement in health and medical research. Canberra: NHMRC & CHF; 2016 [cited 2022 Apr 22]. Available from: www.nhmrc.gov.au/about-us/publications/statement-consumer-and-community-involvement-health-and-medical-research